slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,48 USD | -9,20% | -18,68% | -57,47% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 3,02 mln. 3,31 mln. 3,11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 10 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,11% |
Recentste transcriptie over Altamira Therapeutics Ltd.
1 dag | -9,20% | ||
1 week | -18,68% | ||
Lopende maand | -28,50% | ||
1 maand | -12,43% | ||
3 maanden | -38,33% | ||
6 maanden | -55,95% | ||
Lopend jaar | -57,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01-11-21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01-03-18 |
Mats Blom
BRD | Director/Board Member | 59 | 01-04-17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01-04-03 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,5 | +1,35% | 23 410 |
17-04-24 | 1,48 | -9,20% | 90 008 |
16-04-24 | 1,63 | -1,81% | 56 575 |
15-04-24 | 1,66 | -9,29% | 120 702 |
12-04-24 | 1,83 | +0,55% | 41 161 |
slotkoers Nasdaq, 17 april 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-57,47% | 3,32 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,84 mld. | |
-0,44% | 21,48 mld. | |
-18,35% | 20,82 mld. | |
-7,45% | 18,6 mld. | |
-40,31% | 16,81 mld. | |
-26,84% | 13,78 mld. | |
+0,59% | 13,4 mld. | |
+20,86% | 11,06 mld. |